According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -โน12.3 B. In 2023 the company made an earning of -โน18.98 B an increase over its 2022 earnings that were of -โน20.51 B.The earnings displayed on this page is the company's Pretax Income.